Morepen Laboratories (MOREPENLAB) Share Price Fall Streak: Second Straight Session Lower
- October 9, 2026
- Posted by: Kunal Singla
- Category: News
Morepen Laboratories Share Price is trading lower in its second straight session, with the cumulative move across the streak at 12.13% from Rs 146.8. The latest price event is confirmed by the numbers, but they do not establish a company-specific cause for the continued decline. At Rs 129, the stock is under pressure again and the pattern is clear enough to draw attention to Morepen Laboratories Share Price Fall Streak as the key market theme today.
The company carries a market capitalisation of Rs 8,043.96 crore and sits in the Mid Cap category, which helps frame the move in a broader context. A run of consecutive lower sessions carries more meaning than a single-day fall because it shows that the weakness has persisted across two trading days. For readers tracking Morepen Laboratories Share Price Fall Streak, the next step is to separate the price move from the fundamentals, sector position and peer comparison that now sit around it.
Morepen Laboratories (MOREPENLAB) Share Price Fall Streak: Consecutive Decline Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 129 |
| Previous Close | Rs 136.6 |
| Today's Move | -Rs 7.60 (-5.56%) |
| Open | Rs 137.6 |
| High | Rs 142.1 |
| Low | Rs 125.85 |
| Market Capitalisation | Rs 8,043.96 crore |
Morepen Laboratories Share Price opened at Rs 137.6, touched a high of Rs 142.1 and a low of Rs 125.85 during the session, and was last traded at Rs 129 as of 09 October 2026 at 12:52:50 PM IST. That leaves the stock Rs 7.6 below the previous close of Rs 136.6, a decline of 5.56% for the session. The intraday range shows that the price traded well below the morning open and nearer to the lower end of the day’s band than the top.
Morepen Laboratories Share Price Fall Streak now matters because the current session adds to the previous day’s weakness rather than reversing it. The two-session cumulative fall of 12.13% from the streak-start base price of Rs 146.8 is a sharper read than one-day movement alone. Morepen Laboratories Share Price therefore remains the central headline, while the market capitalisation of Rs 8,043.96 crore and Mid Cap tag provide the scale at which the move is being absorbed.
For Morepen Laboratories Share Price Fall Streak, the price data says the stock is not just reacting inside one session; it is moving through a second lower leg. That makes the next fundamental read more relevant.
What the Consecutive Declines Show
Morepen Laboratories Share Price Fall Streak is now a second straight session pattern, and that matters because it turns a simple daily decline into a short run of consecutive lower prices. The current quote of Rs 129 sits meaningfully below the streak-start base of Rs 146.8, showing that the move is cumulative rather than isolated. Morepen Laboratories Share Price has therefore lost ground across two sessions, with the latest move adding to the earlier session instead of offsetting it.
For a reader, that changes the interpretation of Morepen Laboratories Share Price Today. A single-day fall can reflect a brief swing, but a second straight session asks whether the current valuation and market positioning deserve fresh attention. Univest figures confirm the price action, but they do not point to a specific company trigger. Morepen Laboratories Share Price Fall Streak is therefore best read as a verified pattern first, and only then as a stock analysis question.
Morepen Laboratories (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,043.96 crore |
| P/E Ratio | 53.26x |
| P/B Ratio | 5.75x |
| ROE | 7.96% |
| ROCE | 10.19% |
| EPS | Rs 2.56 |
| Book Value Per Share | Rs 23.78 |
| Dividend Yield | 0.15% |
Morepen Laboratories (MOREPENLAB) fundamental metrics show P/E 53.26x, P/B 5.75x, ROE 7.96%, ROCE 10.19%. Taken on their own, these numbers offer context rather than a trading signal.
Morepen Laboratories has a market capitalisation of Rs 8,043.96 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 53.26x, P/B at 5.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.28x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 53.26x |
| Benchmark Median P/E | 31.28x |
| Benchmark Average P/E | 47.09x |
| Benchmark P/E Range | 3.56x to 678.22x |
| Company P/B Ratio | 5.75x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.25x |
| Company ROE | 7.96% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 10.19% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 8,043.96 crore |
| Benchmark Median Market Cap | Rs 821.44 crore |
| Benchmark Average Market Cap | Rs 14,054.13 crore |
Morepen Laboratories (MOREPENLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Morepen Laboratories (MOREPENLAB) has a P/E ratio of 53.26x, which is above the benchmark median of 31.28x, a difference of +70.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Morepen Laboratories (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.61%, a difference of -31.44%. Morepen Laboratories (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.46%, a difference of -24.29%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,27,861.41 | 34.76 | 4.86 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,54,318.9 | 85.21 | 14.11 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,79,153.26 | 81.53 | 19.81 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,111.94 | 24.65 | 4.13 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,034.16 | 98.83 | 19.16 | 18.31 | 18.2 |
Morepen Laboratories (MOREPENLAB) has a P/E ratio of 53.26x compared with the displayed peer median of 81.53x. The comparison is relative and should not be read as a recommendation. Its ROE of 7.96% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Morepen Laboratories (MOREPENLAB) has a market capitalisation of Rs 8,043.96 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- Morepen Laboratories Share Price Fall Streak is in its second straight session, with the cumulative decline now at 12.13% from Rs 146.8.
- Morepen Laboratories Share Price traded at Rs 129, below the previous close of Rs 136.6 and inside a wide intraday band.
- The company’s P/E of 53.26 remains above the industry median, which keeps valuation in focus after the fall.
- ROE of 7.96% and ROCE of 10.19% are below the same-industry medians in the benchmark snapshot.
- Morepen Laboratories Share Price sits in the Mid Cap category with a market capitalisation of Rs 8,043.96 crore, which helps frame the move.
About Morepen Laboratories
Morepen Laboratories operates in the Pharmaceuticals & Drugs industry within Healthcare, so Morepen Laboratories Share Price should be read in the context of a regulated pharmaceutical business. The company is part of a sector where valuation, return ratios and market capitalisation often differ widely across peers. For Morepen Laboratories Share Price Fall Streak, the useful business context is simply that the stock belongs to an industry where the benchmark set is broad and the comparison group is large. That helps explain why valuation and peer positioning matter as much as the daily move itself.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories (MOREPENLAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Morepen Laboratories Share Price can be tracked on Univest alongside the latest traded price, fundamental ratios, 52-week levels and market insights. Readers using Univest can follow Morepen Laboratories Share Price Fall Streak, review valuation context and keep an eye on the company’s market-cap profile in one place. The page is useful when price action and fundamentals need to be checked together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Morepen Laboratories Share Price falling today?
Ans. Morepen Laboratories Share Price is lower in a second straight session, with the latest trade at Rs 129 and the move down 5.56% from the previous close. According to Univest data, no company-specific catalyst is established.
What is the current Morepen Laboratories Share Price?
Ans. Morepen Laboratories Share Price was last traded at Rs 129 as of 09 October 2026 at 12:52:50 PM IST. It moved between Rs 125.85 and Rs 142.1 during the session and remained below the previous close.
How much has Morepen Laboratories Share Price fallen in the streak?
Ans. Morepen Laboratories Share Price Fall Streak shows a cumulative decline of 12.13% from the streak-start base price of Rs 146.8. The current move is the second straight lower session, so the two-day pattern matters more than one day alone.
What does the market capitalisation tell us about Morepen Laboratories ?
Ans. Morepen Laboratories has a market capitalisation of Rs 8,043.96 crore and sits in the Mid Cap category. That places Morepen Laboratories Share Price in a company-size bracket that is larger than many sector names but still below the.
Is Morepen Laboratories Share Price expensive versus peers?
Ans. Morepen Laboratories Share Price trades at a P/E of 53.26, above the same-industry median of 31.28 and above several peers such as Cipla and Zydus Lifesciences. It is still below Divi's Laboratories and Laurus Labs on that measure.
What do ROE and ROCE show for Morepen Laboratories ?
Ans. Morepen Laboratories reports ROE of 7.96% and ROCE of 10.19%. Both sit below the same-industry benchmark medians, so Morepen Laboratories Share Price is being viewed against return ratios that are not at the sector centre.
What are the key valuation ratios for Morepen Laboratories Share Price?
Ans. Morepen Laboratories Share Price is backed by a P/E of 53.26, a P/B of 5.75, EPS of Rs 2.56, book value of Rs 23.78 and dividend yield of 0.15%. Those figures shape the fundamental read after the decline.
How does Morepen Laboratories compare with the sector benchmark?
Ans. Morepen Laboratories Share Price stands above the same-industry median on P/E and P/B, while ROE and ROCE are below the benchmark medians. The comparison set includes 199 companies, which makes the relative read broad-based.
Should investors track Morepen Laboratories Share Price on Univest?
Ans. Yes, because Morepen Laboratories Share Price Fall Streak combines a lower quote, higher-than-median valuation and return ratios below the benchmark medians. Univest lets readers monitor the latest traded price, ratios and 52-week levels in one place.
